These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9649089)

  • 21. [The influence of tocolytic drugs usage in the third trimester of pregnancy on obstetric and neonatal outcomes].
    Ochrem D; Kaim I; Majewska R; Jaworowski A; Sowa A; Jędrychowski W
    Przegl Lek; 2015; 72(7):343-8. PubMed ID: 26817346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrohysterography during pregnancy: preliminary report.
    Gondry J; Marque C; Duchene J; Cabrol D
    Biomed Instrum Technol; 1993; 27(4):318-24. PubMed ID: 8369867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tocolytic treatment for the management of preterm labour: a systematic review.
    Tan TC; Devendra K; Tan LK; Tan HK
    Singapore Med J; 2006 May; 47(5):361-6. PubMed ID: 16645683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tocolytic therapy for the prevention of preterm labor.
    Miller DD
    J Intraven Nurs; 1995; 18(5):223-8. PubMed ID: 7562221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
    Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
    Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor.
    Steinwall M; Bossmar T; Brouard R; Laudanski T; Olofsson P; Urban R; Wolff K; Le-Fur G; Akerlund M
    Gynecol Endocrinol; 2005 Feb; 20(2):104-9. PubMed ID: 15823830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial.
    Guinn DA; Goepfert AR; Owen J; Wenstrom KD; Hauth JC
    Am J Obstet Gynecol; 1998 Oct; 179(4):874-8. PubMed ID: 9790362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of uterine contraction: mechanisms in preterm labor.
    Buxton IL; Crow W; Mathew SO
    AACN Clin Issues; 2000 May; 11(2):271-82. PubMed ID: 11235436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestational agents for treating threatened or established preterm labour.
    Su LL; Samuel M; Chong YS
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006770. PubMed ID: 20091604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cervical length to the efficacy of nifedipine and bed rest for inhibiting threatened preterm labor.
    Chawanpaiboon S; Sutantawibul A
    J Med Assoc Thai; 2012 May; 95(5):636-43. PubMed ID: 22994021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the contemporary treatment of preterm labor: a comparison with a historical cohort.
    Wagner P; Sonek J; Abele H; Sarah L; Hoopmann M; Brucker S; Wu Q; Kagan KO
    Arch Gynecol Obstet; 2017 Jul; 296(1):27-34. PubMed ID: 28484835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor.
    Bisits A; Madsen G; Knox M; Gill A; Smith R; Yeo G; Kwek K; Daniel M; Leung TN; Cheung K; Chung T; Jones I; Toohill J; Tudehope D; Giles W
    Am J Obstet Gynecol; 2004 Sep; 191(3):683-90. PubMed ID: 15467526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term tocolysis--sense and nonsense in current practice].
    Semczuk M
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):137-42. PubMed ID: 15537254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
    Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
    J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor.
    Larmon JE; Ross BS; May WL; Dickerson GA; Fischer RG; Morrison JC
    Am J Obstet Gynecol; 1999 Dec; 181(6):1432-7. PubMed ID: 10601925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocolysis in women with advanced preterm labor: a secondary analysis of a randomized clinical trial.
    Klauser CK; Briery CM; Tucker AR; Martin RW; Magann EF; Chauhan SP; Morrison JC
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):696-700. PubMed ID: 25747947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate.
    Lurie S; Gur D; Sadan O; Glezerman M
    J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Factors Contributing to Antenatal Corticosteroid Administration in Patients Presenting with Threatened Preterm Labor.
    Bode L; McKinzie AH; Gidia NM; Ibrahim SA; Haas DM
    Am J Perinatol; 2024 May; 41(S 01):e1917-e1924. PubMed ID: 37279789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.